BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2012
View Archived Issues
Virus-mediated neuroprotection demonstrated in model of Parkinson's disease
Read More
New protein kinase modulators designed by Ambit Biosciences
Read More
Lexicon Pharmaceuticals provides first description of early development of LX-4211
Read More
Researchers at Vertex Pharmaceuticals identify new selective PLK1 inhibitor
Read More
Gruenenthal team prepares novel voltage-gated potassium channel modulators
Read More
Merck & Co. synthesizes novel ERK inhibitors
Read More
Scientists at Merck KGaA patent new protein kinase inhibitors
Read More
Anacetrapib improves dyslipidemia in Japanese trial
Read More
Antisense therapy shows promise in phase I study
Read More
New details disclosed on phase I cenderitide trial
Read More
Abide Therapeutics and Scynexis announce collaboration
Read More
Phase I trials of e-Therapeutics anticancer drug clear to proceed
Read More
FDA clarifies dose and warning recommendations for antidepressant
Read More
SymBio's notification for phase I rigosertib study accepted in Japan
Read More
Kiklin capsules approved in Japan
Read More
U.S. university researchers prepare novel c-Met inhibitors
Read More
GSK and DSP set to copromote antidepressant in Japan
Read More
Apokyn approved for marketing in Japan
Read More
New mTOR inhibitors presented by Merck & Co.
Read More
Zeria files for approval of oral phosphate hypophosphatemia drug in Japan
Read More
Chugai obtains approval in Japan for cystic fibrosis treatment
Read More
Toray and Taiho discontinue codevelopment of beta3-adrenoceptor agonist
Read More
Pfizer and Astellas amend Lipitor licensing agreement
Read More
New product approved for T-cell leukemia-lymphoma
Read More
GenSpera advances phase I study of lead chemotherapeutic agent
Read More
Optimer and Astellas enter commercialization agreement for fidaxomicin tablets
Read More